Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the ...

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

We recently compiled a list of the Weak Earnings, Outlook Drag Shares of These 10 Firms on Thursday. In this article, we are ...

West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong ...

West Pharmaceutical reported Q4 earnings and revenue above expectations but issued a weak 2025 forecast. William Blair ...

For 2025, West Pharmaceutical guided for sales between $2.88 billion and $2.91 billion as well as adjusted earnings per-share in the range of $6 and $6.20. Analysts polled by FactSet expected $3.04 ...

West Pharmaceutical (WST) is down -29.6%, or -$95.25 to $227.03.Maximize Your Portfolio with Data Driven Insights:Leverage the power of ...

(WST) on Thursday reported fourth-quarter profit of $130.1 million. The Exton, Pennsylvania-based company said it had net ...

In its fourth quarter 2024 investor letter, Conestoga Capital Advisors emphasized stocks such as West Pharmaceutical Services, Inc. (NYSE:WST). West Pharmaceutical Services, Inc. (NYSE:WST ...

West Pharmaceutical Services has a 1-year low of $265.00 and a 1-year high of $413.70. The stock has a market cap of $24.30 billion, a P/E ratio of 49.78, a P/E/G ratio of 19.82 and a beta of 1.01.

Looking at the universe of stocks we cover at Dividend Channel, on 2/7/25, West Pharmaceutical Services, Inc. (Symbol: WST), SouthState Corp (Symbol: SSB), and Pinnacle Financial Partners Inc ...